With this new agreement, Efemia bladder support will soon be available to buy from five pharmacy chains in Sweden as similar agreements have been signed with Apoteket AB, Apotek Hjärtat, Apotea and Kronans Apotek.

“It is exciting that Efemia bladder support will become available to buy also via LloydsApotek. We are very pleased to see that the product is becoming increasingly available in Sweden via pharmacy chains as well as healthcare regions, and we hope to succeed in creating a similar development also in other European countries going forward together with our regional partners,” says Invent Medic’s CEO Karin Bryder.

About LloydsApotek
At present, LloydsApotek operates 76 full-service pharmacies in Sweden with many pharmacy-related services, and a complete e-commerce that offers prescription drugs and a wide range of self-care. As recently as the autumn of 2019, a collaboration with Coop was established, and the pharmacies are now in selected grocery stores. LloydsApotek is owned by McKesson Europe, one of the leading international service companies in pharmaceuticals, pharmacies and healthcare. McKesson operates in 14 countries around the world and employs approximately 39,000 people.

For more information please contact
Karin Bryder, CEO
Phone: +46 (0)723811710
E-mail: info@inventmedic.com 

Invent Medic Sweden AB, Company registration number 556682-1046, has developed a medical device for non-surgical relief of female stress urinary incontinence. The inventors behind the product, Jan Clarén and Lars-Olof Henriksson, have been involved in the development and performance of the surgical method TVT, which is now known as the Golden Standard for surgical treatment of female stress incontinence. The product is based on the same scientific basis and has similar mechanism of action as the surgical method but is based on a non-surgical support and is designed so that the woman can use the product when needed. This product has the potential to satisfy a major medical need and could thus have a significant market value. Invent medic's vision is to offer new and innovative medical devices and treatment methods to women with the goal of improving their health and quality of life. The offer shall include safe, effective and safe products and treatment methods that should be easy to use and which will provide health economic benefits to society. Invent Medic Sweden AB is listed on Aktietorget. Ticker is IMS and the share's ISIN code is SE0007603402. For more information see www.inventmedic.com and www.spotlightstockmarket.com.